Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Maxime Luu, Marc Bardou, Philippe Bonniaud & Françoise Goirand. (2016) Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1503-1511.
Read now
Read now
Oded Scheuerman, Joseph Meyerovitch, Nufar Marcus, Vered Hoffer, Erez Batt & Ben-Zion Garty. (2009) The September Epidemic of Asthma in Israel. Journal of Asthma 46:7, pages 652-655.
Read now
Read now
Stefan Walzer. (2007) What do parents want from their child’s asthma treatment?. Therapeutics and Clinical Risk Management 3:1, pages 167-175.
Read now
Read now
Articles from other publishers (21)
Xue-qing Yu, Shu-guang Yang, Han Li, Yang Xie, Jian-sheng Li & Pan Zhang. (2019) Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-16.
Crossref
Crossref
Fernanda Agapito P?ssaro Wilmer, Rosemeri Maurici, Carlos Alberto Kuntz Naz?rio, Kahio C?sar Kuntz Naz?rio, Paula Fernanda Agapito P?ssaro, Helena Elisa Piazza, Rennan Almir Bertoldi, Em?lio Pizzichini & M?rcia Margaret Menezes Pizzichini. (2015) Temporal trends in the prevalence of asthma and rhinoconjunctivitis in adolescents. Revista de Sa?de P?blica 49:0.
Crossref
Crossref
Toshitaka Morishima, Hiroshi Ikai & Yuichi Imanaka. (2013) Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Asthma in Japan and the Value of Responder Prediction Methods Based on a Multinational Trial. Value in Health Regional Issues 2:1, pages 29-36.
Crossref
Crossref
Cameron C. Lee, Scott C. Sheridan & Shao Lin. (2012) Relating Weather Types to Asthma-Related Hospital Admissions in New York State. EcoHealth 9:4, pages 427-439.
Crossref
Crossref
Young-Il Koh, Jae-Uoong Shim, Jeongook Wi & Yong Eun Kwon. (2012) The Role of Natural Killer T Cells in the Pathogenesis of Acute Exacerbation of Human Asthma. International Archives of Allergy and Immunology 158:2, pages 131-141.
Crossref
Crossref
CHRISTOPHER K.W. LAI, FANNY W.S. KO, ARVIND BHOME, TERESITA S. DE GUIA, GARY W.K. WONG, BIN M.Z. ZAINUDIN, AN N. NANG, WATCHARA BOONSAWAT, SANG H. CHO, KIRTHI D. GUNASEKERA, JIAN G. HONG, JENG-YUAN HSU, NHUNG N. VIET, FAISAL YUNUS & AMARTYA MUKHOPADHYAY. (2011) Relationship between asthma control status, the Asthma Control Test? and urgent health-care utilization in Asia. Respirology 16:4, pages 688-697.
Crossref
Crossref
Jason Cunningham, Kaninika Basu, Roger Tavendale, Colin N.A. Palmer, Helen Smith & Somnath Mukhopadhyay. (2011) The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults. Annals of Allergy, Asthma & Immunology 106:5, pages 381-386.
Crossref
Crossref
Michelle Gon?alves de Souza Tavares, M?rcia Margaret Menezes Pizzichini, Leila John Marques Steidle, Nazar? Ot?lia Naz?rio, Cristiane Cinara Rocha, Ma?ra Chiaradia Perraro & Em?lio Pizzichini. (2010) Tradu??o e adapta??o cultural do Asthma Control Scoring System (Sistema de Escore para Controle Abrangente da Asma) para uso no Brasil. Jornal Brasileiro de Pneumologia 36:6, pages 683-692.
Crossref
Crossref
Carolina Cisneros, Joaquín Quiralte, Margarita Capel, Miguel Ángel Casado & Carl Mellstrom. (2013) Análisis coste-efectividad de budesonida/formoterol en el tratamiento de mantenimiento y a demanda (Symbicort SMART®) frente a salmeterol/fluticasona más terbutalina, en el tratamiento del asma persistente en España. PharmacoEconomics Spanish Research Articles 7:4, pages 163-175.
Crossref
Crossref
Kristin D. Wilson, Sheniz Moonie, David A. Sterling, Kathleen N. Gillespie & Richard S. Kurz. (2009) Examining the Consulting Physician Model to Enhance the School Nurse Role for Children With Asthma. Journal of School Health 79:1, pages 1-7.
Crossref
Crossref
R. Niven, K.F. Chung, Z. Panahloo, M. Blogg & G. Ayre. (2008) Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study. Respiratory Medicine 102:10, pages 1371-1378.
Crossref
Crossref
K. Basu, C. N. A. Palmer, B. J. Lipworth, W. H. Irwin McLean, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, F. J. D. Smith, A. Mitra & S. Mukhopadhyay. (2008) Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 63:9, pages 1211-1217.
Crossref
Crossref
S. D. Sullivan & F. Turk. (2008) An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 63:6, pages 670-684.
Crossref
Crossref
E.D. Bateman, D. Cheung, J. Lapa e Silva, U.M. G?hring, M. Sch?fer & R. Engelst?tter. (2008) Randomized comparison of ciclesonide 160 and 640?g/day in severe asthma. Pulmonary Pharmacology & Therapeutics 21:3, pages 489-498.
Crossref
Crossref
Rob Horne, David Price, Jen Cleland, Rui Costa, Donna Covey, Kevin Gruffydd-Jones, John Haughney, Svein Hoegh Henrichsen, Alan Kaplan, Arnulf Langhammer, Anders Østrem, Mike Thomas, Thys van der Molen, J Christian Virchow & Siân Williams. (2007) Can asthma control be improved by understanding the patient's perspective?. BMC Pulmonary Medicine 7:1.
Crossref
Crossref
D. Price, A. Wirén & P. Kuna. (2007) Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy 62:10, pages 1189-1198.
Crossref
Crossref
Romain Kessler, Elisabeth Ståhl, Claus Vogelmeier, John Haughney, Elyse Trudeau, Claes-Göran Löfdahl & Martyn R. Partridge. (2006) Patient Understanding, Detection, and Experience of COPD Exacerbations. Chest 130:1, pages 133-142.
Crossref
Crossref
Bernd Brüggenjürgen, Dagmar Selim, Peter Kardos, Kai Richter, Claus Vogelmeier, Stephanie Roll, Wolfgang Meyer-Sabellek, Roland Buhl & Stefan N. Willich. (2012) Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. PharmacoEconomics 23:7, pages 723-731.
Crossref
Crossref
Sadie Clayton. (2005) Paediatric asthma: overcoming barriers to an improved quality of life. British Journal of Nursing 14:2, pages 80-85.
Crossref
Crossref
P.W. Ind, B. Ställberg & S.N. Willich. (2004) Adjustable maintenance dosing with budesonide/formoterol (Symbicort®) reduces treatment costs in asthma. International Journal of Clinical Practice 58, pages 33-41.
Crossref
Crossref
Sixten Borg, ?sa Ericsson, Jadwiga Wedzicha, Amund Gulsvik, Bo Lundb?ck, Gavin C. Donaldson & Sean D. Sullivan. (2004) A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease. Value in Health 7:2, pages 153-167.
Crossref
Crossref